Terms: = Endocrine gland cancer AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1 AND Prognosis
46 results:
1. The relationship between thyroid peroxidase antibody and differentiated thyroid cancer: a systematic review and meta-analysis.
Zhang H; Tian L; Wang X; Shi X
Front Endocrinol (Lausanne); 2024; 15():1349041. PubMed ID: 38476675
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic value of CT-based radiomics in grade 1-2 pancreatic neuroendocrine tumors.
Heo S; Park HJ; Kim HJ; Kim JH; Park SY; Kim KW; Kim SY; Choi SH; Byun JH; Kim SC; Hwang HS; Hong SM
Cancer Imaging; 2024 Feb; 24(1):28. PubMed ID: 38395973
[TBL] [Abstract] [Full Text] [Related]
3. Identification of calcium and integrin-binding protein 1 as a reprogrammed glucose metabolism mediator to restrict immune cell infiltration in the stromal compartment of pancreatic ductal adenocarcinoma.
Ma J; Song Y; Zhuang T; Yang H; Yang X; Zheng J; Luo J; Xia Y; Fei X; Chan DW; Wu D; Xu P; Ni P; Dai J; Xu D; Hu Y
Front Immunol; 2023; 14():1158964. PubMed ID: 37187730
[TBL] [Abstract] [Full Text] [Related]
4. B cells and tertiary lymphoid structures are associated with survival in papillary thyroid cancer.
Li YY; Li SJ; Liu MC; Chen Z; Li L; Shen F; Liu QZ; Xu B; Lian ZX
J Endocrinol Invest; 2023 Nov; 46(11):2247-2256. PubMed ID: 37004696
[TBL] [Abstract] [Full Text] [Related]
5. Immune profiling and prognostic model of pancreatic cancer using quantitative pathology and single-cell RNA sequencing.
Chen K; Wang Q; Liu X; Tian X; Dong A; Yang Y
J Transl Med; 2023 Mar; 21(1):210. PubMed ID: 36944944
[TBL] [Abstract] [Full Text] [Related]
6. [The expression and significance of protease activated receptor 2 in ovarian epithelial carcinoma].
Liu SH; Ma YM; Zhang YN; Zhao XH; Wang HY; Li B
Zhonghua Zhong Liu Za Zhi; 2023 Jan; 45(1):64-73. PubMed ID: 36709122
[No Abstract] [Full Text] [Related]
7. Anticancer Benefit of Metformin in Patients With Early-Stage Pancreatic cancer: A Retrospective Cohort Study.
Chen Y; Qian FJ; Ye ZQ; Xie WX; He YD; Huang JR; Tian L; Gu DN
Technol Cancer Res Treat; 2022; 21():15330338221138208. PubMed ID: 36583563
[No Abstract] [Full Text] [Related]
8. Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic cancer: A Propensity Score Matching Analysis.
Ouyang H; Ma W; Si T; Liu D; Chen P; Gerdtsson AS; Song J; Ni Y; Luo J; Yan Z
Clin Colorectal Cancer; 2023 Mar; 22(1):111-119. PubMed ID: 36473779
[TBL] [Abstract] [Full Text] [Related]
9. Is increased chronological age a contraindication to debulking surgery for elderly patients with advanced ovarian cancer?
Park SJ; Mun J; Yim GW; Lee M; Chung HH; Kim JW; Park NH; Song YS; Kim HS
J Obstet Gynaecol; 2022 Oct; 42(7):3254-3259. PubMed ID: 36000804
[TBL] [Abstract] [Full Text] [Related]
10. Patterns of Lymph Node Metastasis and Optimal Surgical Strategy in Small (≤20 mm) Gastroenteropancreatic Neuroendocrine Tumors.
Cai Y; Liu Z; Jiang L; Ma D; Zhou Z; Ju H; Zhu Y
Front Endocrinol (Lausanne); 2022; 13():871830. PubMed ID: 35937823
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic values of B7-H3, B7-H4, and HHLA2 expression in human pancreatic cancer tissues based on mihc and spatial distribution analysis.
Zhu Y; Chen J; Liu Y; Zheng X; Feng J; Chen X; Jiang T; Li Y; Chen L
Pathol Res Pract; 2022 Jun; 234():153911. PubMed ID: 35489125
[TBL] [Abstract] [Full Text] [Related]
12. The Immunological Role of CDK4/6 and Potential Mechanism Exploration in Ovarian cancer.
Liu C; Huang Y; Cui Y; Zhou J; Qin X; Zhang L; Li X; Li Y; Guo E; Yang B; Li X; Fan J; Li X; Fu Y; Liu S; Hu D; Xiao R; Wang Z; Dou Y; Wang W; Li W; Yang X; Liu J; Peng W; Qin T; You L; Lu F; Sun C
Front Immunol; 2021; 12():799171. PubMed ID: 35095879
[TBL] [Abstract] [Full Text] [Related]
13. Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for prognosis and Immunotherapy.
Li R; He Y; Zhang H; Wang J; Liu X; Liu H; Wu H; Liang Z
Front Immunol; 2021; 12():690056. PubMed ID: 34335594
[TBL] [Abstract] [Full Text] [Related]
14. The underlying molecular mechanism and drugs for treatment in adrenal cortical carcinoma.
Ma C; Xiong J; Su H; Li H
Int J Med Sci; 2021; 18(13):3026-3038. PubMed ID: 34220331
[No Abstract] [Full Text] [Related]
15. Real-world patterns of adjuvant chemotherapy treatment for patients with resected pancreatic adenocarcinoma.
Abdel-Rahman O; Spratlin J; Koski S
Med Oncol; 2021 Feb; 38(2):18. PubMed ID: 33534008
[TBL] [Abstract] [Full Text] [Related]
16. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study.
Kim IH; Choi MH; Lee IS; Hong TH; Lee MA
BMC Cancer; 2021 Jan; 21(1):77. PubMed ID: 33461517
[TBL] [Abstract] [Full Text] [Related]
17. The age threshold of the 8th edition AJCC classification is useful for indicating patients with aggressive papillary thyroid cancer in clinical practice.
Kaliszewski K; Diakowska D; Nowak Ł; Wojtczak B; Rudnicki J
BMC Cancer; 2020 Nov; 20(1):1166. PubMed ID: 33256657
[TBL] [Abstract] [Full Text] [Related]
18. Three Distinct Stroma Types in Human Pancreatic cancer Identified by Image Analysis of Fibroblast Subpopulations and Collagen.
Ogawa Y; Masugi Y; Abe T; Yamazaki K; Ueno A; Fujii-Nishimura Y; Hori S; Yagi H; Abe Y; Kitago M; Sakamoto M
Clin Cancer Res; 2021 Jan; 27(1):107-119. PubMed ID: 33046515
[TBL] [Abstract] [Full Text] [Related]
19. circSFMBT1 promotes pancreatic cancer growth and metastasis via targeting miR-330-5p/PAK1 axis.
Xu S; Lei SL; Liu KJ; Yi SG; Yang ZL; Yao HL
Cancer Gene Ther; 2021 Apr; 28(3-4):234-249. PubMed ID: 32855541
[TBL] [Abstract] [Full Text] [Related]
20. Quality of Life in Papillary Thyroid Microcarcinoma Patients Undergoing Radiofrequency Ablation or Surgery: A Comparative Study.
Lan Y; Luo Y; Zhang M; Jin Z; Xiao J; Yan L; Zhu Y
Front Endocrinol (Lausanne); 2020; 11():249. PubMed ID: 32499754
[No Abstract] [Full Text] [Related]
[Next]
